Skip to content

CRISPR-Cas9 Gene Therapy for Motor Neurone Disease with C9ORF72 Mutations

A gene-editing approach to the most-common genetic cause of MND

Published: 9th March 2021
CRISPR-Cas9 Gene Therapy for Motor Neurone Disease with C9ORF72 Mutations
catalin, https://stock.adobe.com/uk/159579265, stock.adobe.com
IP Status
  • Know-how based
Seeking
  • Development partner
  • Commercial partner
  • Seeking investment